Drugs / AVE0657
last change Mar 2009 re-read 3 minutes ago

AVE0657

Developed for
central sleep apnea due to periodic breathing · heart failure · obstructive sleep apnea syndrome
Investigated by
Sanofi

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00694720 Jun 2008 → Mar 2009 central sleep apnea due to periodic breathing, heart failure Sanofi Terminated No outcome recorded
Phase 2 NCT00614250 Jan 2008 → Jan 2009 obstructive sleep apnea syndrome Sanofi Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as AVE0657 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00694720 ↗
1

NCT00614250 ↗